Evidence map›Paper›PMID 36235403›Full record

ReviewPlants (Basel, Switzerland)2022

Enabling Trade in Gene-Edited Produce in Asia and Australasia: The Developing Regulatory Landscape and Future Perspectives.

Michael G K Jones, John Fosu-Nyarko, Sadia Iqbal, Muhammad Adeel, Rhodora Romero-Aldemita, Mahaletchumy Arujanan, Mieko Kasai, Xun Wei, Bambang Prasetya, Satya Nugroho and 9 more

Abstract readReview
In one paragraph

Review in Plants (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Engineered microorganisms for environmental release: current situation and future perspectives.International microbiology : the official journal of the Spanish Society for Microbiology · 2026
    Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. GMOs or non-GMOs? The CRISPR Conundrum.Frontiers in plant science · 2023
    Review
  17. Review
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Michael G K JonesCrop Biotechnology Research Group, Centre for Crop and Food Innovation, Food Futures Institute, Murdoch University, Perth, WA 6150, Australia.ORCID 0000-0001-5002-0227
John Fosu-NyarkoCrop Biotechnology Research Group, Centre for Crop and Food Innovation, Food Futures Institute, Murdoch University, Perth, WA 6150, Australia.ORCID 0000-0002-2997-7881
Sadia IqbalCrop Biotechnology Research Group, Centre for Crop and Food Innovation, Food Futures Institute, Murdoch University, Perth, WA 6150, Australia.
Muhammad AdeelCrop Biotechnology Research Group, Centre for Crop and Food Innovation, Food Futures Institute, Murdoch University, Perth, WA 6150, Australia.ORCID 0000-0003-3307-6100
Rhodora Romero-AldemitaISAAA-BioTrust Global Knowledge Center on Biotechnology, International Service for the Acquisition of Agri-Biotech Applications (ISAAA), IRRI, Los Banos 4031, Philippines.
Mahaletchumy ArujananMalaysian Biotechnology Information Centre, Monash University Malaysia, Jalan Lagoon Selatan, Bandar Sunway 47500, Malaysia.
Mieko KasaiJapan Plant Factory Association, 6-2-1 Kashiwanoha Kashiwa, Chiba 277-0012, Japan.
Xun WeiZhongzhi International Institute of Agricultural Biosciences, Research Center of Biology and Agriculture, Shunde Graduate School, University of Science and Technology Beijing, Beijing 100024, China.ORCID 0000-0001-9828-6796
Bambang PrasetyaNational Biosafety Committee of Genetically Engineered Products (KKH-PRG), Research Center for Testing Technology and Standards, National Research and Innovation Agency (BRIN), Central Jakarta 10340, Indonesia.ORCID 0000-0002-4256-4192
Satya NugrohoResearch Center for Genetic Engineering, Research Organization for Life Sciences and Environment, National Research and Innovation Agency (BRIN), Central Jakarta 10340, Indonesia.ORCID 0000-0002-5204-3411
Osman MewettAustralian Seed Federation, 20 Napier Cl, Deakin, Canberra, ACT 2600, Australia.
Shahid MansoorNational Institute for Biotechnology and Genetic Engineering (NIBGE), Faisalabad 44000, Pakistan.
Muhammad J A AwanNational Institute for Biotechnology and Genetic Engineering (NIBGE), Faisalabad 44000, Pakistan.ORCID 0000-0001-6163-7740
Reynante L OrdonioCrop Biotech Center, Philippine Rice Research Institute, Munoz 3119, Philippines.
S R RaoSri Balaji Vidyapeeth University, Pondicherry 607402, India.
Abhijit PoddarMGM Advanced Research Institute, Pondicherry 607402, India.ORCID 0000-0002-6775-1090
Penny HundlebyJohn Innes Centre, Norwich, Research Park, Norwich NR4 7UH, UK.
Nipon IamsupasitBiotechnology Alliance Association, Bangkok 10900, Thailand.
Kay KhooRegulatory Affairs Manager, Seeds Asia-Pacific, BASF Australia Ltd., 12/28 Freshwater Pl, Southbank, VIC 3006, Australia.ORCID 0000-0002-0149-5119

Funding

Biotechnology and Biological Sciences Research Council (BBSRC) Institute Strategic Programmes GRO; GEN [BB/J004588/1] [BB/P013511/1]Department of Agriculture, Forestry and Fisheries(formerly DAWE), Government of Australia, Project Assisting Small Exporters (PASE), Building Capacity for Small Exporters to Exploit' new breeding technologies' 4-FA4N7WL
6 · The paper itself

Abstract

Genome- or gene-editing (abbreviated here as 'GEd') presents great opportunities for crop improvement. This is especially so for the countries in the Asia-Pacific region, which is home to more than half of the world's growing population. A brief description of the science of gene-editing is provided with examples of GEd products. For the benefits of GEd technologies to be realized, international policy and regulatory environments must be clarified, otherwise non-tariff trade barriers will result. The status of regulations that relate to GEd crop products in Asian countries and Australasia are described, together with relevant definitions and responsible regulatory bodies. The regulatory landscape is changing rapidly: in some countries, the regulations are clear, in others they are developing, and some countries have yet to develop appropriate policies. There is clearly a need for the harmonization or alignment of GEd regulations in the region: this will promote the path-to-market and enable the benefits of GEd technologies to reach the end-users.

Indexed as

AsiaAsia-PacificAustralasiabiosafetyCas9cropsGEdgene editinggenome editingharmonizationpath-to-marketregulationsscience diplomacytrade

Identifiers

PMID36235403
PMCPMC9571430

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.